These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 17216047)

  • 1. Molecular modelling.
    Barril X; Soliva R
    Mol Biosyst; 2006 Dec; 2(12):660-81. PubMed ID: 17216047
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular modeling of hydration in drug design.
    Mancera RL
    Curr Opin Drug Discov Devel; 2007 May; 10(3):275-80. PubMed ID: 17554853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuum and discrete calculation of fractional contributions to solvation free energy.
    Morreale A; Gelpí JL; Luque FJ; Orozco M
    J Comput Chem; 2003 Oct; 24(13):1610-23. PubMed ID: 12926005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal complexes in medicinal chemistry: new vistas and challenges in drug design.
    Thompson KH; Orvig C
    Dalton Trans; 2006 Feb; (6):761-4. PubMed ID: 16437168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The many roles of computation in drug discovery.
    Jorgensen WL
    Science; 2004 Mar; 303(5665):1813-8. PubMed ID: 15031495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of AMANDA, a new algorithm for selecting highly relevant regions in Molecular Interaction Fields.
    Durán A; Martínez GC; Pastor M
    J Chem Inf Model; 2008 Sep; 48(9):1813-23. PubMed ID: 18693718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranking poses in structure-based lead discovery and optimization: current trends in scoring function development.
    Rajamani R; Good AC
    Curr Opin Drug Discov Devel; 2007 May; 10(3):308-15. PubMed ID: 17554857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular descriptor based on a molar refractivity partition using Randic-type graph-theoretical invariant.
    Padrón JA; Carrasco R; Pellón RF
    J Pharm Pharm Sci; 2002; 5(3):258-66. PubMed ID: 12553894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead optimization via high-throughput molecular docking.
    Joseph-McCarthy D; Baber JC; Feyfant E; Thompson DC; Humblet C
    Curr Opin Drug Discov Devel; 2007 May; 10(3):264-74. PubMed ID: 17554852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based calculation of drug efficiency indices.
    Hetényi C; Maran U; García-Sosa AT; Karelson M
    Bioinformatics; 2007 Oct; 23(20):2678-85. PubMed ID: 17804436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New roles for structure in biology and drug discovery.
    Russell RB; Eggleston DS
    Nat Struct Biol; 2000 Nov; 7 Suppl():928-30. PubMed ID: 11103989
    [No Abstract]   [Full Text] [Related]  

  • 13. Starting from scratch.
    Chapman T
    Nature; 2004 Jul; 430(6995):113. PubMed ID: 15229610
    [No Abstract]   [Full Text] [Related]  

  • 14. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening.
    Tanrikulu Y; Schneider G
    Nat Rev Drug Discov; 2008 Aug; 7(8):667-77. PubMed ID: 18636071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational approaches to modeling drug transporters.
    Chang C; Swaan PW
    Eur J Pharm Sci; 2006 Apr; 27(5):411-24. PubMed ID: 16274971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases.
    Smith PA; Sorich MJ; Low LS; McKinnon RA; Miners JO
    J Mol Graph Model; 2004 Jul; 22(6):507-17. PubMed ID: 15182810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico screening of drug databases for TSE inhibitors.
    Lorenzen S; Dunkel M; Preissner R
    Biosystems; 2005 May; 80(2):117-22. PubMed ID: 15823410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calorimetry and thermodynamics in drug design.
    Chaires JB
    Annu Rev Biophys; 2008; 37():135-51. PubMed ID: 18573076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.